Israel has signed a deal to buy five million Covid-19 vaccine doses from Novavax, the health ministry said.
The vaccines are due to arrive in Israel in the coming months, pending regulatory approval. Financial details of the deal, which includes the option for an additional five million doses, were not disclosed, according to Reuters.
Novavax's protein-based vaccine will be administered in two doses and has been found effective against a number of variants, the ministry said. It will be an alternative for those who do not want a vaccine that uses messenger RNA (mRNA) technology.
